Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Helminth-associated systemic immune activation and HIV co-receptor expression: response to albendazole/praziquantel treatment.

Chachage M, Podola L, Clowes P, Nsojo A, Bauer A, Mgaya O, Kowour D, Froeschl G, Maboko L, Hoelscher M, Saathoff E, Geldmacher C.

PLoS Negl Trop Dis. 2014 Mar 27;8(3):e2755. doi: 10.1371/journal.pntd.0002755.

2.

Understanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency viruses.

Affranchino JL, González SA.

Viruses. 2014 Jan 16;6(1):264-83. doi: 10.3390/v6010264. Review.

3.

MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.

Grupping K, Selhorst P, Michiels J, Vereecken K, Heyndrickx L, Kessler P, Vanham G, Martin L, Ariën KK.

Retrovirology. 2012 May 2;9:36. doi: 10.1186/1742-4690-9-36.

4.

Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection.

Elahi S, Niki T, Hirashima M, Horton H.

Blood. 2012 May 3;119(18):4192-204. doi: 10.1182/blood-2011-11-389585.

5.

Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes.

Zhukovsky MA, Basmaciogullari S, Pacheco B, Wang L, Madani N, Haim H, Sodroski J.

PLoS One. 2010 Oct 13;5(10):e13249. doi: 10.1371/journal.pone.0013249.

6.

Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors.

McEwan WA, McMonagle EL, Logan N, Serra RC, Kat P, Vandewoude S, Hosie MJ, Willett BJ.

J Virol. 2008 Nov;82(21):10953-8. doi: 10.1128/JVI.01312-08.

8.

Blocking the docking of HIV-1.

McKnight A, Weiss RA.

Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10581-2. No abstract available.

10.

CD4-independent, CCR5-dependent simian immunodeficiency virus infection and chemotaxis of human cells.

Iyengar S, Schwartz DH, Clements JE, Hildreth JE.

J Virol. 2000 Aug;74(15):6720-4.

11.

Binding of HIV-2 envelope glycoprotein to CD8 molecules and related chemokine production.

Akimoto H, Kaneko H, Sekigawa I, Hashimoto H, Kaneko Y, Yamamoto N.

Immunology. 1998 Oct;95(2):214-8.

12.

Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry.

Owen SM, Ellenberger D, Rayfield M, Wiktor S, Michel P, Grieco MH, Gao F, Hahn BH, Lal RB.

J Virol. 1998 Jul;72(7):5425-32.

13.
14.

Human immunodeficiency virus type 2 envelope glycoprotein binds to CD8 as well as to CD4 molecules on human T cells.

Kaneko H, Neoh LP, Takeda N, Akimoto H, Hishikawa T, Hashimoto H, Hirose S, Karaki S, Takiguchi M, Nakauchi H, Kaneko Y, Yamamoto N, Sekigawa I.

J Virol. 1997 Nov;71(11):8918-22.

15.

Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2.

Sol N, Ferchal F, Braun J, Pleskoff O, Tréboute C, Ansart I, Alizon M.

J Virol. 1997 Nov;71(11):8237-44.

18.
19.

Cell-surface receptors for retroviruses and implications for gene transfer.

Miller AD.

Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11407-13. Review.

Items per page

Supplemental Content

Support Center